超声在克罗恩病靶向治疗早期疗效评估中的应用OACSTPCD

Crohn's disease(CD)is a chronic inflammatory bowel disease with complicated patho-genesis and prolonged condition.In recent years,with the development of targeted therapy,biological a-gents have been widely used in the treatment of CD,which has significantly improved the prognosis of CD patients.If the efficacy evaluation can be carried out at the early stage of targeted therapy,it may help to figure out the patients who can benefit from the treatment and optimize the treatment plan for the ineffective patients in time.In the evaluation of CD activity and efficacy,ultrasound has the advantages of high accu-racy,no radiation and high patient acceptance,and therefore has potential clinical application value in the early efficacy evaluation of CD targeted therapy.This article reviews the research progress to provides a ref-erence for optimizing the treatment plan for CD patients.